Abstract:
Revolutionizing Anti-Aging Efficacy ThroughIntelligent Nano-Delivery
Blue Eyes Biotech CO., Ltd. unveils agroundbreaking nano-encapsulation platform engineered to overcome the criticalchallenge of low transdermal absorption for high-value anti-aging actives. Ourproprietary lipid-based nanocarriers significantly enhance the bioavailabilityof boswellic acid (from Boswellia serrata) and ergothioneine (mushroom-derived)– two clinically proven ingredients hampered by poor skin permeability.
Independent studies validate our technologyincreases dermal retention of boswellic acid by 210% and ergothioneine by 340%versus conventional serums. This breakthrough addresses a key pain point forcosmetic, nutraceutical, and pharmaceutical manufacturers seeking to maximizeROI from premium plant extracts. By optimizing particle size (<80nm) andsurface charge, our carriers facilitate deep epidermal delivery withoutcompromising ingredient stability or sustainability credentials.
As a vertically integrated supplier, BlueEyes Biotech ensures traceability from ethically wildcrafted botanicals toGMP-certified nano-actives. Our scalable solutions reduce formulation costs byextending active functionality while meeting global regulatory standards (ISO16128, COSMOS). Technical dossiers with in-vivo efficacy data available forqualified partners.
Elevate your anti-aging portfolio withbio-enhanced, market-ready solutions. Contact our R&D team to requestsample technical specifications and absorption studies: [email protected] |Explore innovations: www.blueeyes-bio.com